This may explain why women are more likely to develop lupus

Lupus

Every year, 16,000 cases of lupus are reported in the United States — 9 out of 10 of them in women. Scientists have long believed sex differences help explain women’s predisposition for the autoimmune disease. But researchers said last week that they may now have one explanation for why exactly the presence of two X chromosomes increases the chances that a person will develop lupus.

Dozens of genes have been associated with lupus, but in a new study, researchers focused on the overexpression of the gene Tlr7, which sits on the X chromosome.

For their study, researchers studied the immune cells of healthy women, measuring the expression of Tlr7. They found that in some cells, both copies of the gene were making the protein TLR7.

The researchers also discovered that the overexpression of Tlr7 — what is called biallelism, because both alleles are being expressed — led to changes in the cells and the proteins they produce that could induce autoimmune issues.

[Researcher Jean-Charles] Guéry said his research did not show how or why exactly Tlr7 avoids X chromosome inactivation, but that it suggested limiting TLR7 levels might offer a new therapeutic avenue to treating lupus — a step that would be easier than trying to inactivate the second copy of the Tlr7 gene.

Read full, original post: New study points to why so many more women develop lupus than men

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-07-01-at-2.49.48-PM
Dr. TikTok and male fertility: Viral claims tout GLP-1 drugs as fertility boosters. What does the science say?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
a-mature-farmer-working-in-the-field-at-sunrise-harvesting-crops-generated-by-ai-photo
What’s the prospect of developing gene-altered crops that are more nutritious and resist climate disruption
reverse-aging
Rapamycin: Here’s the skinny on the anti-aging pill that increases the lifespan—of mice by 10%
ChatGPT-Image-Jun-25-2026-02_53_56-PM
Embryo gene editing is on the horizon, stirring mixed emotions
png-upside-food-syn-bio-cultured-meat
Regulating cultured meat around the world
Screenshot-2026-07-21-at-6.22.06-PM
The Indian physician’s one-woman battle against health disinformation on Wikipedia
ChatGPT-Image-Jul-6-2026-02_25_26-PM
40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline.
ChatGPT-Image-Jul-17-2026-12_42_10-PM
Viewpoint: RFK, Jr. is setting up a panel to compensate people who claim they were injured by a COVID vaccine–no proof needed 
YearReview Grift
Viewpoint: A practical guide to evaluating social media wellness hype
ChatGPT-Image-Jun-17-2026-03_29_08-PM
Viewpoint: What’s the impact of the U.S. abandoning support for global health?
UK scientists support loosening restrictions limiting embryo research
Are we edging closer to precisely, and safely, editing human embryos?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.